INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2001

Higher serum enterolactone concentrations were significantly linked to a lower risk of breast cancer in Finnish women.

A case-control study within the Kuopio Breast Cancer Study examined 194 cases who entered prior to diagnosis and 208 controls. Mean serum enterolactone was significantly lower in cases than in controls (20 nmol/l vs. 26 nmol/l, P = 0.003). After adjusting for known breast cancer risk factors, women in the highest quintile of enterolactone had an odds ratio of 0.38 (95% CI, 0.18-0.77; P for trend, 0.03) compared to the lowest quintile. The inverse association was observed in both premenopausal and postmenopausal women, and high enterolactone levels were linked to higher intakes of rye products, tea, dietary fiber, and vitamin E.

Shows an association, not proof of cause and effect.

Study type
Case-control study
Who was studied
194 breast cancer cases (68 premenopausal, 126 postmenopausal) and 208 community-based controls in Finland
What was measured
Risk of breast cancer in relation to serum enterolactone concentration

THE PAPER

Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.

Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H. Cancer Epidemiol Biomarkers Prev, 2001.

PubMed 11319174 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.